Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2017

View Archived Issues

Generon initiates phase I trial of A-337 in Australia

Combined stem cell-virotherapy reduces experimental ovarian cancer

Aequus files Canadian CTA for anti-nausea patch AQS-1303

[18F]JHU-16907, a novel PET probe targeting Mer tyrosine kinase

HbA1c reductions seen with Roche's GIP/GLP-1 receptor agonist NNC-0090-2746 in type 2 diabetes

Peloton partners with University of Texas on ubiquitin ligase research for cancer

RedHill reports phase III results on Bekinda for acute gastroenteritis and gastritis

Q BioMed enters license agreement for uttrocide B for liver cancer

GVK Biosciences patents PI3Kbeta inhibitors

Taiho Pharmaceutical discloses androgen receptor antagonists

Arnuity Ellipta launched in Japan

Mitsubishi Tanabe Pharma discovers MC1 receptor agonists

Lieber Institute for Brain Development divulges COMT inhibitors

R-Pharm CJSC patent describes dual ALK and EGFR inhibitors

Human Longevity and Merck KGaA establish cancer biomarker agreement

Sirnaomics reports findings on STP-705 for liver fibrosis

Johnson & Johnson Innovation announces new collaborations

First-in-human data for MVT-2163 PET imaging in CA 19-9-positive malignancies

Johnson & Johnson completes Actelion acquisition

FDA grants orphan drug designation to ResQ's LipidRescue

Immune Pharmaceuticals to regain worldwide rights to Ceplene

Discovery and in vivo evaluation of two PET radioligands of muscarinic acetylcholine M1 receptor

Ionis initiates phase I/II study of IONIS-MAPTRx in mild Alzheimer's disease

NICE recommends olaratumab in combination with doxorubicin for the treatment of soft tissue sarcoma

Launch of NGN-PET project to explore and model neuron-glial networks in neuropathic pain

Arginase inhibitor CB-1158 well tolerated in first-in-human study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...